Use of selective decontamination of the digestive tract in United Kingdom intensive care units

Anaesthesia

Volumn 64, Issue 1, 2009, Pages 46-49

  Bastin, A J ^a   Ryanna, K B ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFUROXIME; COLISTIN; FLUCONAZOLE; GENTAMICIN; NEOMYCIN; NYSTATIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ASEPSIS; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONFERENCE PAPER; HEALTH SURVEY; HUMAN; INTENSIVE CARE UNIT; INTUBATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; QUESTIONNAIRE; SELECTIVE DECONTAMINATION OF THE DIGESTIVE TRACT; UNITED KINGDOM; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CROSS INFECTION; DIGESTIVE SYSTEM; EPIDEMIOLOGY; HEALTH PERSONNEL ATTITUDE; INTENSIVE CARE; METHODOLOGY; MICROBIOLOGY; MULTICENTER STUDY; PROFESSIONAL PRACTICE; STATISTICS; UTILIZATION REVIEW; VENTILATOR ASSOCIATED PNEUMONIA; WASTE MANAGEMENT;

ANTIBIOTIC PROPHYLAXIS; ATTITUDE OF HEALTH PERSONNEL; CROSS INFECTION; DECONTAMINATION; DIGESTIVE SYSTEM; DRUG RESISTANCE, BACTERIAL; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; PROFESSIONAL PRACTICE;

EID: 58249086019     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05676.x     Document Type: Conference Paper

References (24)

1. Alp E, Voss A. Ventilator associated pneumonia and infection control. Annals of Clinical Microbiology and Antimicrobials 2006; 5:7.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 2002; 165: 867-903.
3. Safdar N, Dezfulian C, Collard H, Saint S. Clinical and economic consequences of ventilator associated pneumonia: a systematic review. Critical Care Medicine 2005; 33: 2184-93.
4. Kreuger WA, Lenhart FP, Neeser G, et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. American Journal of Respiratory and Critical Care Medicine 2002; 166: 1029-37.
5. de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362: 1011-16.
6. de La Cal MA, Cerda E, Garcia-Hierro P, et al. Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial. Annals of Surgery 2005; 241: 424-30.
7. Misset B, Artigas A, Bihari D, et al. Short-term impact of the European Consensus Conference on the use of selective decontamination of the digestive tract with antibiotics in ICU patients. Intensive Care Medicine 1996; 22: 981-4.
8. Bion JF, Badger I, Crosby HA, et al. Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine 1994; 22: 40-9.
9. Rolando N, Wade JJ, Stangou A, et al. Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transplantation and Surgery 1996; 2: 8-13.
10. Winter R, Humphreys H, Pick A, MacGowan AP, Willatts SM, Speller DC. A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection. Journal of Antimicrobial Chemotherapy 1992; 30: 73-87.
11. Armstrong PJ, Barr JG, Webb CH, Blair PH, Rowlands BJ. Epidemiology of Pseudomonas aeruginosa in an intensive care unit using selective decontamination of the digestive tract. Journal of Hospital Infection 1992; 20: 199-208.
12. Humphreys H, Winter R, Pick A. The effect of selective decontamination of the digestive tract on gastrointestinal enterococcal colonization in ITU patients. Intensive Care Medicine 1992; 18: 459-63.
13. Blair P, Rowlands BJ, Lowry K, Webb H, Armstrong P, Smilie J. Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit. Surgery 1991; 110: 303-9.
14. European Antimicrobial Resistance Surveillance System Annual Report 2006. http://www.rivm.nl/earss/Images/ EARSS%202006%20Def-tcm61-44176.pdf (accessed 27 May 2008).
15. Heininger A, Meyer E, Schwab F, Marschal M, Unertl K, Krueger WA. Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance. Intensive Care Medicine 2006; 32: 1569-76.
16. Leone M, Albanese J, Antonini F, Nguyen-Michel A, Martin C. Long-term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients. Critical Care Medicine 2003; 31: 2090-5.
17. Lingnau W, Berger J, Javorsky F, Fille M, Alleberger F, Benzer H. Changing bacterial ecology during a five-year period of selective intestinal decontamination. Journal of Hospital Infection 1998; 39: 195-206.
18. Sanchez Garcia M, Cambronero Galache JA, Lopez Diaz J, et al. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. American Journal of Respiratory and Critical Care Medicine 1998; 158: 908-16.
19. Cerda E, Abella A, de la Cal MA, et al. Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit: a 9-year prospective study. Annals of Surgery 2007; 245: 397-407.
20. Silvestri L, van Saene HK, Milanese M, et al. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. European Respiratory Journal 2004; 23: 921-6.
21. de la Cal MA, Cerda E, van Saene HK, et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. Journal of Hospital Infection 2004; 56: 175-83.
22. Silvestri L, Milanese M, Oblach L, et al. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. American Journal of Infection Control 2002; 30: 391-9.
23. Chan EY, Ruest A, Meade MO, Cook DJ. Oral decontamination for the prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. British Medical Journal 2007; 334: 889.
24. Rello J, Koulenti D, Blot S, et al. Oral care practices in intensive care units: a survey of 59 European ICUs. Intensive Care Medicine 2007; 33: 1066-70.